Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Copy number variation in CCND1 gene is implicated in the pathogenesis of sporadic parathyroid carcinoma.

Zhao L, Sun LH, Liu DM, He XY, Tao B, Ning G, Liu JM, Zhao HY.

World J Surg. 2014 Jul;38(7):1730-7. doi: 10.1007/s00268-014-2455-9.

PMID:
24510244
2.

Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians.

Varshney S, Bhadada SK, Saikia UN, Sachdeva N, Behera A, Arya AK, Sharma S, Bhansali A, Mithal A, Rao SD.

Eur J Endocrinol. 2013 Jun 7;169(1):109-16. doi: 10.1530/EJE-13-0085. Print 2013 Jul.

3.

Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins.

Costa-Guda J, Imanishi Y, Palanisamy N, Kawamata N, Phillip Koeffler H, Chaganti RS, Arnold A.

Endocrine. 2013 Oct;44(2):489-95. doi: 10.1007/s12020-013-9903-4. Epub 2013 Feb 24.

4.

Molecular pathogenesis of primary hyperparathyroidism.

Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa J, Gallagher J, Wild Y, Saucier K.

J Bone Miner Res. 2002 Nov;17 Suppl 2:N30-6. Review.

PMID:
12412775
5.

Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.

Hemmer S, Wasenius VM, Haglund C, Zhu Y, Knuutila S, Franssila K, Joensuu H.

Am J Pathol. 2001 Apr;158(4):1355-62.

6.

Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.

Cryns VL, Thor A, Xu HJ, Hu SX, Wierman ME, Vickery AL Jr, Benedict WF, Arnold A.

N Engl J Med. 1994 Mar 17;330(11):757-61.

7.

Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.

Newey PJ, Nesbit MA, Rimmer AJ, Attar M, Head RT, Christie PT, Gorvin CM, Stechman M, Gregory L, Mihai R, Sadler G, McVean G, Buck D, Thakker RV.

J Clin Endocrinol Metab. 2012 Oct;97(10):E1995-2005. doi: 10.1210/jc.2012-2303. Epub 2012 Aug 1.

8.

Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.

Sulaiman L, Haglund F, Hashemi J, Obara T, Nordenström J, Larsson C, Juhlin CC.

PLoS One. 2012;7(9):e46325. doi: 10.1371/journal.pone.0046325. Epub 2012 Sep 28.

9.
10.

Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study.

Hsi ED, Zukerberg LR, Yang WI, Arnold A.

J Clin Endocrinol Metab. 1996 May;81(5):1736-9.

PMID:
8626826
11.

Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.

Lee JY, Kim SY, Mo EY, Kim ES, Han JH, Maeng LS, Lee AH, Eun JW, Nam SW, Moon SD.

Int J Oncol. 2014 Aug;45(2):641-50. doi: 10.3892/ijo.2014.2477. Epub 2014 May 29.

PMID:
24889687
12.

Loss of parafibromin expression in a subset of parathyroid adenomas.

Juhlin C, Larsson C, Yakoleva T, Leibiger I, Leibiger B, Alimov A, Weber G, Höög A, Villablanca A.

Endocr Relat Cancer. 2006 Jun;13(2):509-23.

13.

Aberrant methylation of the HRPT2 gene in parathyroid carcinoma.

Hewitt KM, Sharma PK, Samowitz W, Hobbs M.

Ann Otol Rhinol Laryngol. 2007 Dec;116(12):928-33.

PMID:
18217513
14.

Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis.

Stojadinovic A, Hoos A, Nissan A, Dudas ME, Cordon-Cardo C, Shaha AR, Brennan MF, Singh B, Ghossein RA.

Hum Pathol. 2003 Jan;34(1):54-64.

PMID:
12605367
15.

Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology.

Forsberg L, Björck E, Hashemi J, Zedenius J, Höög A, Farnebo LO, Reimers M, Larsson C.

Eur J Endocrinol. 2005 Mar;152(3):459-70.

16.

Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma.

Haven CJ, van Puijenbroek M, Karperien M, Fleuren GJ, Morreau H.

J Pathol. 2004 Jan;202(1):86-94.

PMID:
14694525
17.
18.

Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.

Pardi E, Marcocci C, Borsari S, Saponaro F, Torregrossa L, Tancredi M, Raspini B, Basolo F, Cetani F.

J Clin Endocrinol Metab. 2013 Jul;98(7):2800-10. doi: 10.1210/jc.2012-4029. Epub 2013 Apr 30.

PMID:
23633209
19.

Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.

Costa-Guda J, Soong CP, Parekh VI, Agarwal SK, Arnold A.

Horm Cancer. 2013 Oct;4(5):301-7. doi: 10.1007/s12672-013-0147-9. Epub 2013 May 29.

PMID:
23715670
20.

[A study of gene amplification and expression of cyclin D1 in hepatocellular carcinoma].

Xu JM, Wen JM, Zhang M, Lü GL, Wu LZ, Wang WS.

Zhonghua Bing Li Xue Za Zhi. 2004 Feb;33(1):26-30. Chinese.

PMID:
14989924

Supplemental Content

Support Center